Beyond Air (XAIR) Financials: Revenue & Earnings
$1.46M
Market Cap
—
P/E
—
Forward P/E
—
Score
XAIR price $2.30 -0.06 -2.54%
Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing…
Beyond Air, Inc. (XAIR) trades at $2.30, with a market cap of $1.46M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$1.46M
Market Cap
—
P/E
—
Forward P/E
—
Score